טוען...
Treat-and-extend therapy using intravitreal aflibercept for neovascular age-related macular degeneration: 2-year real-world practice data from Slovenia
BACKGROUND: To assess visual outcomes over 24 months in patients with neovascular age-related macular degeneration (nAMD) who initiated intravitreal aflibercept therapy under a treat-and-extend (TE) regimen in real-world settings. METHODS: In this retrospective, observational, multicentre study in S...
שמור ב:
| הוצא לאור ב: | BMC Ophthalmol |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6302519/ https://ncbi.nlm.nih.gov/pubmed/30572850 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12886-018-1005-x |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|